Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes
出版年份 2021 全文链接
标题
Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes
作者
关键词
NAFLD, MAFLD, Fibroscan, Diabetes, Statins
出版物
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume -, Issue -, Pages 154752
出版商
Elsevier BV
发表日期
2021-03-12
DOI
10.1016/j.metabol.2021.154752
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease
- (2020) Jung Il Lee et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
- (2020) Stefano Ciardullo et al. DIABETES CARE
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes
- (2019) Fabio Nascimbeni et al. ATHEROSCLEROSIS
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- Statins: Old drugs as new therapy for liver diseases?
- (2018) Elisa Pose et al. JOURNAL OF HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study
- (2016) Yi-Wen Huang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection
- (2015) Yao-Hsu Yang et al. JOURNAL OF HEPATOLOGY
- Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis
- (2015) Ahmed M. Kabel et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome
- (2015) Konstantinos Kargiotis WORLD JOURNAL OF GASTROENTEROLOGY
- Mortality From Chronic Liver Diseases in Diabetes
- (2014) Giacomo Zoppini et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals
- (2014) Catherine E. de Keyser et al. DIGESTIVE AND LIVER DISEASE
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Liver biopsy
- (2008) Don C. Rockey et al. HEPATOLOGY
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More